256 related articles for article (PubMed ID: 34830854)
1. The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development. Yuan H; Lu Y; Chan YT; Zhang C; Wang N; Feng Y Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830854 [TBL] [Abstract][Full Text] [Related]
2. Sumoylation in liver disease. Zeng M; Liu W; Hu Y; Fu N Clin Chim Acta; 2020 Nov; 510():347-353. PubMed ID: 32710938 [TBL] [Abstract][Full Text] [Related]
3. Increased Small Ubiquitin-like Modifier-Activating Enzyme SAE1 Promotes Hepatocellular Carcinoma by Enhancing mTOR SUMOylation. Chen Y; Peng W; Tao Q; Li S; Wu Z; Zhou Y; Xu Q; Shu Y; Xu Y; Shao M; Chen M; Shi Y Lab Invest; 2023 Jan; 103(1):100011. PubMed ID: 36748193 [TBL] [Abstract][Full Text] [Related]
4. The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol; ; . PubMed ID: 29484374 [TBL] [Abstract][Full Text] [Related]